Common Contracts
6 similar Underwriting Agreement contracts by Insulet Corp, Materialise Nv, Aratana Therapeutics, Inc., Medical Properties Trust Inc
Materialise NV Registered Ordinary Shares in the form of American Depositary Shares (each representing one Ordinary Share, with no nominal value) UNDERWRITING AGREEMENTUnderwriting Agreement • June 14th, 2021 • Materialise Nv • Services-prepackaged software • New York
Materialise NV, a limited liability company (naamloze vennootschap) organized and existing under the laws of the Kingdom of Belgium (“Belgium”) and registered with the Register of Legal Entities of Leuven under the number VAT BE 0441.131.254 (the “Company”), proposes to issue and sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representative (the “Representative”) an aggregate of 4,000,000 ordinary shares, with no nominal value, of the Company (the “Ordinary Shares”) to be delivered in the form of American Depositary Shares (“ADSs”), as set forth on Schedule I hereto (the “Firm ADSs”). The Ordinary Shares issued and sold by the Company under this Agreement are hereinafter referred to as the “Firm Shares.” The Company has also granted to the several Underwriters an option to purchase up to 600,000 additional Ordinary Shares on the terms and for the purposes set forth in Section 2(b) hereof (the “Option Shares”) to be delivered
Materialise NV Registered Ordinary Shares in the form of American Depositary Shares (each representing one Ordinary Share, with no nominal value) UNDERWRITING AGREEMENTUnderwriting Agreement • July 26th, 2018 • Materialise Nv • Services-prepackaged software • New York
Materialise NV, a limited liability company (naamloze vennootschap) organized and existing under the laws of the Kingdom of Belgium (“Belgium”) and registered with the Register of Legal Entities of Leuven under the number VAT BE 0441.131.254 (the “Company”), proposes to issue and sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representative (the “Representative”) an aggregate of 3,000,000 ordinary shares, with no nominal value, of the Company (the “Ordinary Shares”) to be delivered in the form of American Depositary Shares (“ADSs”), as set forth on Schedule I hereto (the “Firm ADSs”). The Ordinary Shares issued and sold by the Company under this Agreement are hereinafter referred to as the “Firm Shares.” The Company has also granted to the several Underwriters an option to purchase up to 450,000 additional Ordinary Shares on the terms and for the purposes set forth in Section 2(b) hereof (the “Option Shares”) to be delivered
4,500,000 Shares ARATANA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT September 17, 2014Underwriting Agreement • September 19th, 2014 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • New York
Aratana Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to you (the “Underwriters”) an aggregate of 4,500,000 shares (the “Firm Shares”) of the common stock, par value $0.001 per share, of the Company (“Common Stock”). The Company also proposes to sell to the Underwriters up to an additional 675,000 shares of Common Stock at the option of the Underwriters (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares.”
UNDERWRITING AGREEMENT MEDICAL PROPERTIES TRUST, INC. 8,300,000 shares of common stock, par value $0.001 per share Underwriting AgreementUnderwriting Agreement • March 11th, 2014 • Medical Properties Trust Inc • Real estate investment trusts • New York
Medical Properties Trust, Inc., a Maryland corporation (the “Company”), proposes to issue and sell the Underwriters listed in Schedule 1 hereto (the “Underwriters”) an aggregate of 7,700,000 shares of common stock, par value $0.001 per share, of the Company (“Common Stock”); and Edward K. Aldag, Jr. (the “Selling Stockholder”) proposes to sell to the Underwriters an aggregate of 600,000 shares of Common Stock. The 7,700,000 shares of Common Stock to be sold by the Company and the 600,000 shares of Common Stock to be sold by the Selling Stockholder are collectively called the “Underwritten Shares.” In addition, the Company has granted the Underwriters an option to purchase up to an additional 1,245,000 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
Insulet Corporation 4,100,000 Shares Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • January 4th, 2013 • Insulet Corp • Surgical & medical instruments & apparatus • New York
Insulet Corporation 3,000,000 Shares Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • December 8th, 2010 • Insulet Corp • Surgical & medical instruments & apparatus • New York
